Viracta Therapeutics (VIRX) Insider Trading & Ownership → (Free Workshop) Advanced “bug-out bag” hacks! (From Warrior Life) (Ad) Free VIRX Stock Alerts $0.67 +0.03 (+5.00%) (As of 06/14/2024 08:52 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Viracta Therapeutics (NASDAQ:VIRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.69%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$25,526.06Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$9,438.05 Get VIRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Viracta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VIRX Insider Buying and Selling by Quarter Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. Viracta Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/27/2024Daniel R ChevallardCFOSell3,405$0.73$2,485.65 11/30/2023Mark RotheraCEOBuy52,094$0.49$25,526.06 11/28/2023Daniel R ChevallardCFOSell3,720$0.50$1,860.00 8/28/2023Daniel R ChevallardCFOSell3,512$1.45$5,092.40 (Data available from 1/1/2013 forward) VIRX Insider Trading Activity - Frequently Asked Questions Who is on Viracta Therapeutics's Insider Roster? The list of insiders at Viracta Therapeutics includes Daniel R Chevallard, Ivor Royston, Lisa Rojkjaer, and Mark Rothera. Learn more on insiders at VIRX. What percentage of Viracta Therapeutics stock is owned by insiders? 10.69% of Viracta Therapeutics stock is owned by insiders. Learn more on VIRX's insider holdings. Which Viracta Therapeutics insiders have been buying company stock? The following insider purchased VIRX shares in the last 24 months: Mark Rothera ($25,526.06). How much insider buying is happening at Viracta Therapeutics? Insiders have purchased a total of 52,094 VIRX shares in the last 24 months for a total of $25,526.06 bought. Which Viracta Therapeutics insiders have been selling company stock? The following insiders have sold VIRX shares in the last 24 months: Daniel R Chevallard ($44,946.21), Ivor Royston ($53,649.79), and Lisa Rojkjaer ($18,159.50). How much insider selling is happening at Viracta Therapeutics? Insiders have sold a total of 44,899 Viracta Therapeutics shares in the last 24 months for a total of $116,755.50 sold. More Insider Trading Tools from MarketBeat Related Companies: ASRT Insider Selling HILS Insider Selling RLMD Insider Selling PMVP Insider Selling ORMP Insider Selling DERM Insider Selling CMRX Insider Selling ASMB Insider Selling ANIX Insider Selling MIST Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The Top 3 Stocks Sold by Insiders This QuarterTop 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks This page (NASDAQ:VIRX) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored"Trump Loophole" Beats InflationThe demise of the "petrodollar" appears imminent. And the implications for Americans could be dire.Colonial Metals | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viracta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.